Consistent with this hypothesis, the patient manifesting with late F‐NHL relapse originated from DLBCL with typical molecular and IHC profile of a GCB neoplasm with BCL2 but not MYC re‐arrangements. This evidence concerns the gene MYC and non-Hodgkin lymphoma.